Implementation and Effect of a Novel Electronic Medical Record Format for Patient Allergy Information
被引:1
作者:
论文数: 引用数:
h-index:
机构:
Nakayama, Masaharu
[1
,2
]
Inoue, Ryusuke
论文数: 0引用数: 0
h-index: 0
机构:
Tohoku Univ Hosp, Med IT Ctr, Sendai, Miyagi, JapanTohoku Univ, Grad Sch Med, Med Informat, Sendai, Miyagi, Japan
Inoue, Ryusuke
[2
]
机构:
[1] Tohoku Univ, Grad Sch Med, Med Informat, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Med IT Ctr, Sendai, Miyagi, Japan
来源:
BUILDING CONTINENTS OF KNOWLEDGE IN OCEANS OF DATA: THE FUTURE OF CO-CREATED EHEALTH
|
2018年
/
247卷
关键词:
Allergy;
Patient profile;
Adverse drug event;
Medical Safety;
CLINICAL DECISION-SUPPORT;
DRUG;
D O I:
10.3233/978-1-61499-852-5-51
中图分类号:
R-058 [];
学科分类号:
摘要:
Adverse drug events (ADEs) are critical. Approximately 10% of fatal ADEs are believed to be allergic reactions. Therefore, sharing patient allergy information is beneficial to medical staff members in avoiding potentially lethal complications. We previously performed a nationwide study of patient allergy information in Japanese hospitals. The report showed that most of the responding hospitals needed a standard format for reporting the information. To establish this, we implemented a novel format for recording patient allergy information into the hospital information system at Tohoku University Hospital; this format was created through vigorous discussion among medical staff members with a variety of specialties, including doctors, nurses, pharmacists, nutritionists, and medical safety managers. In this study, we followed the amount of inputted allergy information and the number of incidents involving medication after implementation. The amount of allergy information inputted increased slightly. Although incidents involving medication also increased slightly, ADEs due to allergy significantly decreased. We believe that our findings will be useful in helping to determine the optimal characteristics of drug allergy information and to improve the dissemination of information regarding potential allergens and subsequent ADEs.